---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-009684"
form_type: "8-K"
ticker: "IMNN"
cik: "0000749647"
company_name: "Imunon, Inc."
filed_at: "2024-03-12T23:59:59+00:00"
generated_at: "2026-06-04T23:32:01.182383+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Imunon CEO Corinne Le Goff resigns; Executive Chairman Tardugno assumes interim leadership

## Summary
- Dr. Corinne Le Goff resigned as President, CEO, and Board member, effective March 15, 2024, to pursue another opportunity.
- Resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Executive Chairman Michael H. Tardugno (former CEO) will lead day-to-day operations until a successor is named.
- Active CEO search is underway; development strategy and key program milestones remain unchanged.
- Milestones: Phase 1 trial of IMNN-101 (COVID-19 booster) prep ongoing; OVATION 2 topline data for IMNN-001 expected summer 2024.

## SEC filing metadata
- accession: 0001493152-24-009684
- form_type: 8-K
- ticker: IMNN
- cik: 0000749647
- company_name: Imunon, Inc.
- filed_at: 2024-03-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/749647/000149315224009684/0001493152-24-009684-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/749647/000149315224009684/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-009684
- JSON: https://secwatch.observer/filing/0001493152-24-009684.json
- Plain text: https://secwatch.observer/filing/0001493152-24-009684.txt

## Key facts
- Executive change
  Corinne Le Goff resigned as President and Chief Executive Officer at Imunon, Inc..
  - Action: resigned
  - Role: President and Chief Executive Officer
  source text: On March 6, 2024, Dr. Corinne Le Goff, Pharm.D., informed the Board of Directors (the “Board”) of Imunon, Inc. (the “Company”) of her resignation from her position as President and Chief Executive Officer of the Company and from the Board, effective as of March 15, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/749647/000149315224009684/0001493152-24-009684-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.